Komosinska-Vassev, K.; Olczyk, P.; Kuźnik-Trocha, K.; Jura-Półtorak, A.; Derkacz, A.; Purchałka, M.; Telega, A.; Olczyk, K.
Circulating C1q/TNF-Related Protein 3, Omentin-1 and NGAL in Obese Patients with Type 2 Diabetes During Insulin Therapy. J. Clin. Med. 2019, 8, 805.
https://doi.org/10.3390/jcm8060805
AMA Style
Komosinska-Vassev K, Olczyk P, Kuźnik-Trocha K, Jura-Półtorak A, Derkacz A, Purchałka M, Telega A, Olczyk K.
Circulating C1q/TNF-Related Protein 3, Omentin-1 and NGAL in Obese Patients with Type 2 Diabetes During Insulin Therapy. Journal of Clinical Medicine. 2019; 8(6):805.
https://doi.org/10.3390/jcm8060805
Chicago/Turabian Style
Komosinska-Vassev, Katarzyna, Pawel Olczyk, Kornelia Kuźnik-Trocha, Agnieszka Jura-Półtorak, Alicja Derkacz, Marcin Purchałka, Alicja Telega, and Krystyna Olczyk.
2019. "Circulating C1q/TNF-Related Protein 3, Omentin-1 and NGAL in Obese Patients with Type 2 Diabetes During Insulin Therapy" Journal of Clinical Medicine 8, no. 6: 805.
https://doi.org/10.3390/jcm8060805
APA Style
Komosinska-Vassev, K., Olczyk, P., Kuźnik-Trocha, K., Jura-Półtorak, A., Derkacz, A., Purchałka, M., Telega, A., & Olczyk, K.
(2019). Circulating C1q/TNF-Related Protein 3, Omentin-1 and NGAL in Obese Patients with Type 2 Diabetes During Insulin Therapy. Journal of Clinical Medicine, 8(6), 805.
https://doi.org/10.3390/jcm8060805